ArticleVascular specialist international2026
Use of Transapical Access for Thoracic Endovascular Aortic Repair in Challenging Aortic Anatomy: A Case Report.
Article in Vascular specialist international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Few cases have reported the use of a transapical approach for thoracic endovascular aortic repair (TEVAR) when standard retrograde device delivery is not feasible. We present the unique case of a 74-year-old female with a history of descending thoracic TEVAR, a physician-modified fenestrated endograft, and ascending aortic repair who presented with an enlarging aortic arch aneurysm requiring intervention. Her native aorta was notably tortuous, and a patient-centered decision was made to proceed with transapical access via a mini-thoracotomy after unsuccessful retrograde endovascular attempts due to severe tortuosity and prior endografts. The stent graft was successfully deployed without type I or III endoleak. The patient recovered without neurologic deficits and was discharged on postoperative day 7. This case highlights transapical access as a feasible alternative route for TEVAR in selected patients with prohibitive anatomy and underscores the importance of multidisciplinary collaboration and timely management of proximal aortic pathology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.